Key issues for HIV testing and counselling in Europe Martin C Donoghoe Programme Manager HIV/AIDS, STI &Viral Hepatitis Programme WHO Europe
Key issues for HIV testing & counselling in Europe HIV epidemics in Europe not under control ART coverage in eastern Europe and central Asia among the worst globally Infection increasing faster than treatment Key populations at higher risk not targeted Many people unaware of HIV status and diagnosis often late Adherence to core principles (3Cs)
HIV epidemic in Europe still not under control Cumulative number of reported cases (in thousands), WHO European Region, 1985 2010 1 600 1 400 1 200 1 000 800 600 absolute numbers, thous sands 1 418 400 200 0 1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 Sources: ECDC/WHO. HIV/AIDS surveillance in Europe 2010. Stockholm: ECDC; 2011. UNGASS country progress reports 2010 for the Russian Federation and Ukraine. Sources: ECDC/WHO. HIV/AIDS surveillance in Europe 2010. Stockholm: ECDC; 2011. UNGASS country progress reports 2010 for the Russian Federation and Ukraine.
People living with HIV: fast growing numbers in eastern Europe and central Asia Estimated number of people living with HIV in Europe, 1990-2010 Estimated people living with HIV (million) 2.6 2.4 2.2 2.0 1.8 1.6 1.4 1.2 1.0 0.8 0.6 0.4 Europe (total estimated) 2 340 000 Eastern Europe and central Asia 1.5 million Western and central Europe 840 000 0.2 0.0 Source: UNAIDS/WHO World AIDS Day Report 2011. Geneva, Joint United Nations Programme on HIV/AIDS, 2011.
100% Newly diagnosed HIV infections by mode of transmission and geographical area, 2010 Men who have sex with men Injecting drug use Heterosexual Other and unknown 90% 17% 13% 80% 42% 70% 60% 40% 45% 50% 40% 4% 24% 30% 20% 10% 39% 4% 29% 41% 0% West Centre East 1% Sources: ECDC/WHO. HIV/AIDS surveillance in Europe 2010. Stockholm: ECDC; 2011 Russian Federation Ministry of Health and Social Development 2010
Estimated ART coverage in eastern Europe and central Asia among the worst globally North Africa and the Middle East Eastern Europe and Central Asia 10% 23% ART also reduces risk of HIV transmission. Donnell D et al. Lancet, 2010, 375(9731):2092 2098 Eastern, Southern and South-East Asia 39% Carribean 60% Latin America 64% Sub-Saharan Africa 49% Global coverage 47% 0% 10% 20% 30% 40% 50% 60% 70% Source: WHO/UNAIDS/UNICEF Universal Access Report 2011
Infection increasing faster than treatment Cumulative number of reported cases and deaths (in thousands), WHO European Region, 1985 2010 1 600 1 400 1 200 1 000 800 600 absolute numbers, thou usands HIV AIDS AIDS deaths People on ART 1 418 559 400 397 200 210 0 1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010. Sources: ECDC/WHO. HIV/AIDS surveillance in Europe 2010. Stockholm: ECDC; 2011. UNGASS country progress reports 2010 for the Russian Federation and Ukraine. ART data from the WHO/UNICEF/UNAIDS monitoring and reporting on the Health Sector response to HIV/AIDS.
Number of HIV tests performed in selected European countries (excl UAT and testing of blood donations) 400000 350000 300000 250000 200000 2004 2009 150000 100000 50000 0 Estonia Lithuania Poland Romania Armenia Azerbaijan Kyrgyzstan Tajikistan
Low rates of HIV testing in key populations Country examples 2009 Lithuania Total tested 190 800 1405 IDUs 79 SW 36 MSM Source: S. Rotberga presentation Kyrgyzstan Total tested 359 887 2193 IDUs 284 SW 15 MSM Source: National AIDS Program data
Rates of HIV testing in key populations in selected countries in eastern Europe and central Asia People who inject drugs (11 countries in 2005, 22 countries in 2007, 29 countries in 2009) Sex workers (9 countries in 2005, 20 countries in 2007, 21 countries in 2009) Men who have sex with men (8 countries in 2005, 24 countries in 2007, 29 countries in 2009) 0 % 10 20 30 40 50 60% Source: AIDSinfo [online database] 2005 2007 2009
Late diagnosis Many new cases are diagnosed at a late stage > 50% presenting late (CD4 < 350) Majority of AIDS deaths among late presenters
WHO Europe HTC Policy Framework: Core principles (1) A public health and human rights imperative Linked to UA to comprehensive, evidence-based HIV prevention, treatment, care and support. Tailored to different settings, populations and client needs Should include PITC and rapid tests when/where appropriate Meet needs of vulnerable populations and expand beyond clinical settings Involve civil society and community-based organizations in providing services
WHO Europe HTC Policy Framework: Core principles (2) Regardless of where and how HIV testing is done 3 Cs should always be observed (consent, confidentiality & counselling) Policies & practices reviewed to eliminate non-voluntary testing Must be accompanied by efforts to ensure supportive social, policy and legal environments Consultations should be undertaken to formulate expansion plans Must be carefully monitored and evaluated
Mandatory testing? Systematic testing in: 20 EU countries* 9 EECA countries** IDUs in 5 out of 20 countries in 6 out of 9 countries Prisoners (at entry): 6 3 - at exit 2 1 SW 3 5 MSM 2 5 Refugees 4 3 Permanent residence/citizenship seekers 2 6 Long term visa applicants 1 4 Military recruits 3 5 Some professional groups 3 7 * Belgium, Cyprus, Czech Republic,Denmark, Estonia, France, Germany, Hungary, Ireland, Italy, Latvia, Lithuania Malta, Netherlands, Poland, Romania, Slovakia, Spain, Sweden, UK **Armenia, Azerbaijan, Georgia, Belarus, Moldova, Kazakhstan,Kyrgyzstan, Tajikistan, Uzbekistan Source: WHO Europe 2011 survey
Rapid testing 60 50 40 30 2008 2010 20 10 0 Uzbekistan Belarus Serbia Moldova Kazakhstan Tajikistan Kyrgyzstan Source: WHO Europe 2011 survey
Recently developed WHO normative documents Delivering HIV test results (Russian translation) Improving HIV testing and counselling services Guide for M&E of national HTC programs PITC ( training tool ) HTC QI handbook
HIV Testing and Counselling Priorities Ensure: HIV testing services meet basic ethical standards: 3Cs referral for all tested to follow up services incl, earliest possible access to treatment Promote PITC for: those attending clinical care with signs and symptoms in TB, STI, viral hepatitis, drug dependence, SRH and PHC where possible, childbirth and postpartum services Ensure: HTC for key populations appropriate HTC models to meet the needs of key populations involvement of non-medical settings and personnel in HTC service provision civil society involvement in policy formulation, program planning, implementation, M&E Avoidance of mandatory or compulsory HTC and disclosure Promote rapid HIV testing
Thank you